Dr. Leiserowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4860 Y St
Ob/Gyn, Suite 2500
Sacramento, CA 95817Phone+1 916-734-4107Fax+1 916-734-6666- Is this information wrong?
Summary
- Dr. Gary Leiserowitz is a Professor and Chair in the Department of Obstetrics and Gynecology. He is a gynecologic oncologist in Sacramento, CA and is affiliated with University of California, Davis Medical Center. He received his medical degree from University of Iowa Carver College of Medicine. He did his residency at UC Davis Medical Center and his fellowship at the Mayo Clinic. He joined the faculty at UC Davis in 1993. He specializes in gynecologic oncology and is experienced in general obstetrics and gynecology, hysterectomy, gynecologic oncology, clinical research, and minimally invasive gynecologic surgery.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gynecologic Oncology, 1990 - 1993
- University of California Davis HealthResidency, Obstetrics and Gynecology, 1986 - 1989
- Ventura County Medical CenterResidency, Family Medicine, 1982 - 1984
- Ventura County Medical CenterInternship, Family Medicine, 1981 - 1982
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1981
Certifications & Licensure
- CA State Medical License 1982 - 2026
- MN State Medical License 1990 - 1994
- IA State Medical License 1982 - 1982
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Top Docs https://usatopdocs.com, 2015-2022
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants Start of enrollment: 2005 Oct 01
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Publications & Presentations
PubMed
- 2 citationsPerspectives of gynecologic oncology fellowship training and preparedness for practice.Zavorsky, G., Nguyen, N., Jang, A., Pomerantz, T., Leiserowitz, G., Brooks, R.> ;Gynecologic Oncology Reports. 2024 Feb 1
- Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer.Tanmoy Mondal, Himanshu Gaur, Brice E N Wamba, Abby Grace Michalak, Camryn Stout, Matthew R Watson, Sophia L Aleixo, Arjun Singh, Salvatore Condello, Roland Faller, Ga...> ;Cell Death and Differentiation. 2023 Nov 1
- Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers.Nancy T Nguyen, Alan Raetz, Dennis Montoya, Vincent Schilling, Caili Tong, Rebecca A Brooks, Gary Leiserowitz, Jeremy Chien> ;Gynecologic Oncology. 2023 Nov 1
- Join now to see all
Press Mentions
- Sacramento Magazine’s Top Doctors 2021December 2nd, 2021
- El Camino Health Nationally Recognized as a Best Maternity Care Hospital by NewsweekFebruary 24th, 2021
- New Birth Control Pills Offer More Protection Against Ovarian CancerOctober 11th, 2018
- Join now to see all
Professional Memberships
- Society of Gynecologic OncologyMember
- Western Association of Gynecologic OncologyMember
- Fellow
Hospital Affiliations
- UC Davis Medical CenterSacramento, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: